Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases

Clinical trial NCT06411639 · WITHDRAWN

Trial details

NCT number: NCT06411639
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Sjogren Disease Systemic Lupus Erythematosus

Start date: 2024-11-25
Primary completion: 2025-12-17
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.